Innovation

Redefining Dry Eye Management

The patented IRPL® Technology

E-Eye is a medical device that has been specifically designed for treating dry eye syndrome due to MGD.

It generates Intense Regulated Pulsed Light by producing perfectly calibrated and homogeneously sequenced light pulses. The sculpted pulses are delivered under the shape of a train of pulses. The energy, spectrum and time period are precisely set to stimulate the Meibomian glands in order for them to return their normal function. E-Eye is the medical solution to treat and to prevent dry eyes.

Made in France. Worldwide distribution.

Our devices and their technology are entirely designed and developed in France.

E-Swin’s manufacturing site has a Quality Management System (QMS) certified ISO 13485 (compliance with European and most countries’ requirements) and MDSAP (compliance with US, Canadian, Brazilian and Australian requirements).

All our devices are CE marked according to EU Regulation (MDR 2017/745) and registered on all continents (North America, South America, Australia, Asia, Middle East).

Our certifications: ISO 13485 / MDSAP / CE (MDR 2017/745)

Our main registrations: EU (MDR 2017/745) / USA* (FDA) / Canada (HC) / Australia (TGA) / Brazil (Anvisa) / China (NMPA) / India (CDSCO) / KSA (SFDA)

*In the United States, E>Eye is not currently FDA-cleared for the treatment of Dry Eye Disease (DED) or Meibomian Gland Dysfunction (MGD).

Concept Design 2019

Presented 2019 –
design studies for future product generations

Presentation Video
Concept design 2019

tearcheck 1st generation
available table-mounted

Voices from the experts